Hepatitis D screening: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
|||
| Line 6: | Line 6: | ||
==Screening== | ==Screening== | ||
The following screening and preventive measures may be applied: | |||
*Patients known to be HBsAg positive who have acute or chronic hepatitis may be tested for hepatitis D. | *Patients known to be HBsAg positive who have acute or chronic hepatitis may be tested for hepatitis D. | ||
Revision as of 11:57, 18 August 2014
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D screening On the Web |
|
American Roentgen Ray Society Images of Hepatitis D screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]
Overview
Screening
The following screening and preventive measures may be applied:
- Patients known to be HBsAg positive who have acute or chronic hepatitis may be tested for hepatitis D.
- Patients who have acute hepatitis B, are not HBsAg positive and who are IgM anti-HBc positive may be tested for HDV.
- Patients with positive HBsAg and/or HDV antibody should be alerted not to share items such as razors or eating and drinking utensils.
- Patients without immunity to HBV should be vaccinated.
The general population, without risk for HBV and HDV does not need screening.
Blood products should also be screened for the presence of HDV and HBV, to prevent infection by blood transfusion and hemodialysis.[1]
For recommendations regarding HBV and HCC screening, refer to Hepatitis B screening[2]
References
- ↑ Hughes SA, Wedemeyer H, Harrison PM (2011). "Hepatitis delta virus". Lancet. 378 (9785): 73–85. doi:10.1016/S0140-6736(10)61931-9. PMID 21511329.
- ↑ Lok AS, McMahon BJ (2004). "[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]" (PDF). Romanian Journal of Gastroenterology. 13 (2): 150–4. PMID 15229781. Retrieved 2012-02-10. Unknown parameter
|month=ignored (help)